To verify that our findings were not restricted to the HeLa-CASP8 KO model and could be validated in the context of a HNSCC model, we performed experiments using the TRAIL-sensitive HNSCC cell line PE/CA-PJ49 (Supplementary Fig. 2A). The gene discussed is CASP8; the disease is head and neck squamous cell carcinoma.